183 related articles for article (PubMed ID: 27624929)
21. Prognostic factors for cutaneous and subcutaneous soft tissue sarcomas in dogs.
Dennis MM; McSporran KD; Bacon NJ; Schulman FY; Foster RA; Powers BE
Vet Pathol; 2011 Jan; 48(1):73-84. PubMed ID: 21139143
[TBL] [Abstract][Full Text] [Related]
22. Characterizing Microscopical Invasion Patterns in Canine Mast Cell Tumours and Soft Tissue Sarcomas.
Russell DS; Townsend KL; Gorman E; Bracha S; Curran K; Milovancev M
J Comp Pathol; 2017 Nov; 157(4):231-240. PubMed ID: 29169616
[TBL] [Abstract][Full Text] [Related]
23. Changes in tumour oxygenation during fractionated hyperthermia and radiation therapy in spontaneous canine sarcomas.
Thrall DE; Larue SM; Pruitt AF; Case B; Dewhirst MW
Int J Hyperthermia; 2006 Aug; 22(5):365-73. PubMed ID: 16891239
[TBL] [Abstract][Full Text] [Related]
24. Reductions in margin length after excision of grade II mast cell tumors and grade I and II soft tissue sarcomas in dogs.
Milovancev M; Townsend KL; Bracha S; Gorman E; Curran K; Russell DS
Vet Surg; 2018 Jan; 47(1):36-43. PubMed ID: 29064583
[TBL] [Abstract][Full Text] [Related]
25. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G
J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107
[TBL] [Abstract][Full Text] [Related]
26. Expression of fibroblast growth factor 23 by canine soft tissue sarcomas.
Hardcastle MR; Dittmer KE
Vet Comp Oncol; 2016 Sep; 14(3):306-17. PubMed ID: 24923416
[TBL] [Abstract][Full Text] [Related]
27. Principles of treatment for soft tissue sarcoma.
Dernell WS; Withrow SJ; Kuntz CA; Powers BE
Clin Tech Small Anim Pract; 1998 Feb; 13(1):59-64. PubMed ID: 9634350
[TBL] [Abstract][Full Text] [Related]
28. Outcomes and prognostic variables associated with primary abdominal visceral soft tissue sarcomas in dogs: A Veterinary Society of Surgical Oncology retrospective study.
Linden D; Liptak JM; Vinayak A; Grimes JA; Sandey M; Smiley W; Matz BM
Vet Comp Oncol; 2019 Sep; 17(3):265-270. PubMed ID: 30666781
[TBL] [Abstract][Full Text] [Related]
29. Histologic grade predicts recurrence for marginally excised canine subcutaneous soft tissue sarcomas.
McSporran KD
Vet Pathol; 2009 Sep; 46(5):928-33. PubMed ID: 19429989
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the extent of neoplastic infiltration in small intestinal tumours in dogs.
Morrice M; Polton G; Beck S
Vet Med Sci; 2019 May; 5(2):189-198. PubMed ID: 30779310
[TBL] [Abstract][Full Text] [Related]
31. Intra-operative imaging of surgical margins of canine soft tissue sarcoma using optical coherence tomography.
Selmic LE; Samuelson J; Reagan JK; Mesa KJ; Driskell E; Li J; Marjanovic M; Boppart SA
Vet Comp Oncol; 2019 Mar; 17(1):80-88. PubMed ID: 30239117
[TBL] [Abstract][Full Text] [Related]
32. Extracellular pH and P-31 magnetic resonance spectroscopic variables are related to outcome in canine soft tissue sarcomas treated with thermoradiotherapy.
Lora-Michiels M; Yu D; Sanders L; Poulson JM; Azuma C; Case B; Vujaskovic Z; Thrall DE; Charles HC; Dewhirst MW
Clin Cancer Res; 2006 Oct; 12(19):5733-40. PubMed ID: 17020978
[TBL] [Abstract][Full Text] [Related]
33. Scar revision for incompletely or narrowly excised soft tissue sarcomas in dogs.
Grimes JA; Rajeev M; Wallace ML; Laver T; Milovancev M
Can Vet J; 2023 Jan; 64(1):70-75. PubMed ID: 36593932
[TBL] [Abstract][Full Text] [Related]
34. Quantitative morphology in canine cutaneous soft tissue sarcomas.
Simeonov R; Ananiev J; Gulubova M
Vet Comp Oncol; 2015 Dec; 13(4):481-4. PubMed ID: 24890665
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of a large soft tissue sarcoma with irreversible electroporation.
Neal RE; Rossmeisl JH; Garcia PA; Lanz OI; Henao-Guerrero N; Davalos RV
J Clin Oncol; 2011 May; 29(13):e372-7. PubMed ID: 21321291
[No Abstract] [Full Text] [Related]
36. Emerging therapeutic approaches for canine sarcomas: Pushing the boundaries beyond the conventional.
Borgatti A; Dickerson EB; Lawrence J
Vet Comp Oncol; 2020 Mar; 18(1):9-24. PubMed ID: 31749286
[TBL] [Abstract][Full Text] [Related]
37. [Current diagnosis and therapy of soft tissue sarcomas in the adult].
Peiper M; Hegewisch-Becker S; Langwieler TE; Bloechle C; Izbicki JR
Schweiz Med Wochenschr; 1999 Oct; 129(42):1545-53. PubMed ID: 10568237
[TBL] [Abstract][Full Text] [Related]
38. [Practice guideline 'Diagnostic techniques for soft tissue tumours and treatment of soft tissue sarcomas (revision)'].
van Geel AN; Wyrdeman HK; Seynaeve C; Hogendoorn PC; Bongaerts AH; Molenaar WM;
Ned Tijdschr Geneeskd; 2005 Apr; 149(17):924-8. PubMed ID: 15884405
[TBL] [Abstract][Full Text] [Related]
39. MR imaging and spectroscopy for prognostic evaluation in soft-tissue sarcomas.
Sostman HD; Prescott DM; Dewhirst MW; Dodge RK; Thrall DE; Page RL; Tucker JA; Harrelson JM; Reece G; Leopold KA
Radiology; 1994 Jan; 190(1):269-75. PubMed ID: 8259418
[TBL] [Abstract][Full Text] [Related]
40. Effect of calcitonin gene related peptide vs sodium nitroprusside to increase temperature in spontaneous canine tumours during local hyperthermia.
Poulson JM; Vujaskovic Z; Gaskin AA; Larue SM; Meyer RE; Prescott DM; Samulski TV; Thrall DE; Dewhirst MW
Int J Hyperthermia; 2004 Aug; 20(5):477-89. PubMed ID: 15277021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
